The company's market capitalisation of almost $2.5 billion, around ten times higher than three years ago, was driven by the commercialisation of its Australian-developed product for Rett syndrome. …
Neuren reports growing US sales of Australian developed product for Rett syndrome
May 10, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Just to be clear, the comment was completely tongue-in-cheek
May 20, 2024 - - Latest News -
Can we just have an honest conversation about Budget and reform
May 20, 2024 - - Podcast -
AstraZeneca welcomes action on co-pays but calls for more on access
May 20, 2024 - - Latest News -
AstraZeneca welcomes action on co-pays but calls for more on access
May 20, 2024 - - Latest News -
Health department makes a major change inside critical division
May 17, 2024 - - Latest News -
Baxter launches the mission and logo of new kidney care company
May 16, 2024 - - Latest News -
NZ Prime Minister says, 'We are recognising that we have a problem'
May 16, 2024 - - Latest News